Fatima Gulzar
Tue, June 16, 2026 astatine 7:53 AM CDT 1 min read
Cerus Corporation (NASDAQ:CERS) is 1 of the 8 Best Genomics Stocks to Buy According to Analysts.
On June 8, Cerus Corporation (NASDAQ:CERS) closed a caller indebtedness installation with MidCap Financial, providing up to $110 million. The steadfast combined a five-year word indebtedness with an asset-backed revolving loan. The institution said the refinancing volition chopped yearly currency involvement disbursal by up to $3.5 cardinal portion reducing its outstanding word indebtedness equilibrium by astir $30 million.The institution utilized archetypal proceeds and currency connected manus to discontinue its existing $65 cardinal word loan. It besides pulled an archetypal $35 cardinal tranche astatine closing and secured entree to an other $30 cardinal successful staged increments. A abstracted five-year revolving installation of up to $45 cardinal adds capableness and flexibility.
Chief Financial Officer Kevin Green said the refinancing "strengthens our fiscal foundation," and pointed retired extended maturities and little borrowing costs. The corp highlighted deferred amortization for 48 months, followed by a 12-month repayment period.Cerus Corporation (NASDAQ:CERS) is progressive successful the research, development, and manufacturing of biomedical and surgical products.
While we admit the imaginable of CERS arsenic an investment, we judge definite AI stocks connection greater upside imaginable and transportation little downside risk. If you're looking for an highly undervalued AI banal that besides stands to payment importantly from Trump-era tariffs and the onshoring trend, spot our escaped study connected the best short-term AI stock.
READ NEXT: 33 Stocks That Should Double successful 3 Years and Cathie Wood 2026 Portfolio: 10 Best Stocks to Buy.
Disclosure: None. Follow Insider Monkey connected Google News.

1 hour ago
1




English (CA) ·
English (US) ·
Spanish (MX) ·